Feb 18, 2016

Caribou Bio’s New CRISPR Patent Isn’t About Gene Editing

Posted by in categories: biotech/medical, genetics

The facts about the CRISPR Patent.

Xconomy San Francisco —

If you ask people who don’t follow biotech too closely what they know about CRISPR, you might get two answers: genetic editing and a big patent fight.

But a new CRISPR patent highlights a lower-profile potential use for the biotechnology: genetic detection and analysis.

Read more

Comments are closed.